A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors
Bristol-Myers Squibb
Bristol-Myers Squibb
GI Innovation, Inc.
Mayo Clinic
Neonc Technologies, Inc.
Genmab
Ocellaris Pharma, Inc.
Tanabe Pharma America, Inc.
Incyte Corporation
NuCana plc
OncoC4, Inc.
Klus Pharma Inc.
RAPT Therapeutics, Inc.
Cybrexa Therapeutics
Salubris Biotherapeutics Inc
Sumitomo Pharma America, Inc.
NextCure, Inc.
Evopoint Biosciences Inc.
pharmaand GmbH
Incyte Corporation
Incyte Corporation